Summary
The supply of GLP-1 drugs like Ozempic has been increasing, but theyre still expensive for most patients. Here are answers to some questions consumers have.
Source: The Wall Street Journal on MSN.com
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
